Novel SYK inhibitor elicits durable Hb response in autoimmune haemolytic anaemia
The highly selective oral spleen tyrosine kinase (SYK) inhibitor sovleplenib has demonstrated significant clinical benefit in patients with warm autoimmune haemolytic anaemia (wAIHA), with durable haemoglobin (Hb) response and a favourable safety profile, as shown in the phase III ESLIM-02 trial.
Sugary drinks, fruit juice implicated in hypertension
Drinking excessive amounts of sugar sweetened beverages and fruit juice has been shown to raise the risk of hypertension, regardless of overall diet quality and physical activity, in a large prospective study.

MIMS is a trusted, accurate and user-friendly medication information platform. Designed to empower both healthcare professionals and general public to support informed healthcare decisions, our leading drug directory provides clear, reliable information on prescription drugs, over-the-counter medications and other medical resources.

Frequently Asked Questions

Absolutely. Our database is continuously updated by medical editors and references authoritative sources, ensuring accuracy and credibility.

Yes. You can access MIMS.com on desktop or mobile, and we also offer an app for on-the-go use.

Use the search bar located at the top of the homepage and enter either the brand name or generic name of the drug.

Go to "Diseases" and use the search bar located at the top of the page and enter the name of the disease.

Go to "Medical News & Updates" to access latest news and medical updates in MIMS.com